Capula Management LTD Sarepta Therapeutics, Inc. Transaction History

Capula Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$93.7 - $141.53 $63,716 - $96,240	-680 Reduced 29.63%	1,615 $209,000
Q4 2023 Feb 12, 2024	SELL	$67.31 - $124.76 $628,136 - $1.16 Million	-9,332 Reduced 80.26%	2,295 $221,000
Q3 2023 Nov 03, 2023	BUY	$102.5 - $123.59 $1.19 Million - $1.44 Million	11,627 New	11,627 $1.41 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.